1) microvessel density in mesenchyme
间质微血管密度
1.
The relationship between microvessel density in mesenchyme and clinicopathological factors in breast carcinoma;
间质微血管密度与乳腺癌临床病理因素的关系
2.
Effect of microvessel density in mesenchyme on the tumor biological behavior in gastric carcinoma;
间质微血管密度对胃癌的肿瘤生物学行为的影响
2) tumor interstitial vascular density
肿瘤间质微血管密度
3) interstitial microvascular density
间质血管密度
1.
Influences of protopanaxdiol to interstitial microvascular density and proliferation activity of liver cancer;
20(S)-原人参二醇对肝癌间质血管密度和肿瘤细胞增殖活性的影响
4) microvessel density
微血管密度
1.
The Effect On Microvessel Density of Glucocorticoid-induced Avascular Necrosis of Femoral Head in Rabbits By Treatment of Tao Hong Si Wu Decoction;
桃红四物汤对激素性股骨头缺血坏死局部微血管密度的影响
2.
Relationships of VEGF and microvessel density with liver metastasis in human colorectal cancer;
VEGF和微血管密度与大肠癌肝转移的关系
3.
Expression of Ang-2 and its relationship with microvessel density in epithelia ovarian carcinoma;
上皮性卵巢癌中促血管生成素-2的表达及其与微血管密度的关系
5) Microvascular Density
微血管密度
1.
Expression of matrix metalloproteinase-7 and microvascular density in oral squamous cell carcinoma and their relationship with invasion and metastasis;
口腔鳞癌中基质金属蛋白酶7的表达和微血管密度与肿瘤侵袭转移的关系
2.
KAI1 and MMP-9 Expression and Microvascular Density in Gastric Carcinoma and Their Relation with Invasion and Metastasis;
KAI1、MMP-9蛋白表达及微血管密度与胃癌浸润和转移的相关性
3.
Prognostic significance of microlymphatic vessel density and microvascular density in colorectal carcinoma;
微淋巴管和微血管密度对结直肠癌的预后意义
6) MVD
微血管密度
1.
Expression and Significance of PCNA Protein and MVD in Pancreatic Adenocarcinoma;
增殖细胞核抗原和微血管密度在胰腺癌中的表达及意义
2.
Detection of expression of RECK and MVD in esophageal squamous cell carcinoma tissue;
食管鳞状细胞癌组织中RECK蛋白的表达与微血管密度检测
3.
Detection of MVD and VEGF in hepatocellular carcinoma tissue;
原发性肝癌组织中血管内皮生长因子、微血管密度检测
补充资料：CO2微泡超声血管造影
CO2微泡超声血管造影
影像学术语。利用CO2微泡作为声学对比剂施行的超声血管成像方法。利用两个注射器与三通管连接，将10ml CO2、10ml肝素化生理盐水及5ml病人自身血液充分混匀制成CO2微泡。常规肝动脉造影后经置于肝固有动脉(或左、右分支)内的导管，以2ml/s的速度缓慢注入CO2微泡。根据CO2微泡在肝实质内充盈程度分为早、中、晚三期。CO2微泡开始充盈肝实质为早期，历时5～10s；CO2微泡持续充盈肝实质为中期，约10～60s；完全从肝实质内清除为晚期，相当于注入CO2微泡后的1～7分钟。此方法的所见与血管造影静脉期相似，但发现小病灶优于血管造影。CO2-Dus对血管造影不能显示的等血管性或少血管性肝细胞癌有价值。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条